School of Pharmacy

Department of Bioengineering and Therapeutic Sciences Professor Joanne Chun, PharmD ’93, PhD ’96 leads the MS in AICD3 program — the first of its kind in the nation focused on AI’s transformation of drug discovery and development. Learn more about how AI-based research benefit patients and how the...

Congratulations to these PharmD students who are among the 2025 scholarship recipients. Scholarships are a key part of financial support students receive to ensure that finances are not a barrier to their success.

Department of Pharmaceutical Chemistry Professors Brian Shoichet, PhD ’91, and Jason Sello, PhD, are leading a collaborative research project to scour millions of compounds — with help from tiny zebrafish — to create anesthetics safe enough to use without an anesthesiologist.

Muhammad Baluom, PhD, an executive director of clinical pharmacology at Eli Lilly and Company, reflects on his journey from becoming a pharmacist in Jerusalem to pursuing postdoctoral studies in the lab of the legendary Leslie Benet, PhD, and to leading the clinical pharmacology programs behind...

The school's second annual PSR Symposium brought together postdocs, specialists, and researchers for a day of scientific presentations, career discussion, and recognition hosted by the Center for Collaborative Innovation.

World No Tobacco Day is an occasion to reflect on UCSF’s national leadership and innovation in tobacco education — with limitless potential to directly reach patients. Department of Clinical Pharmacy Professor Robin Corelli, PharmD, has been taking on nicotine addiction for more than two decades.

On May 27, UCSF School of Pharmacy proudly celebrated the commencement of the PharmD Class of 2025 at Davies Symphony Hall in San Francisco. The moment marked more than the culmination of academic achievement, with cheering family, friends, faculty, and mentors celebrating the achievements of a new...

The latest publication from the lab of Department of Bioengineering and Therapeutic Sciences professor and Vice Dean of Research Tanja Kortemme, PhD, along with a $1.4 million award from the National Science Foundation, recognizes major possibilities and support for her vision of integrating AI and...

Recently published findings reveal how the hypoxic, or low-oxygen, environment characteristic of pancreatic cancer reshapes the proteolytic landscape of the tumor, a discovery that could translate into better diagnostic tools or treatments.